Tech Company Financing Transactions
Sofregen Medical Funding Round
Anzu Partners and private investors participated in a $8 million Series B funding round for Sofregen Medical. The round was announced by the company on 12/18/2019.
Transaction Overview
Company Name
Announced On
12/18/2019
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Series B
Investors
Anzu Partners (Lead Investor)
Proceeds Purpose
The company intends to use the funds to accelerate the development of its technology and to support the commercialization and availability of Silk Voice, a U.S. Food and Drug Administration (FDA)-cleared silk protein treatment for vocal fold medialization and vocal fold insufficiency.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
200 Boston Ave. 1100
Medford, MA 02155
USA
Medford, MA 02155
USA
Phone
Website
Email Address
Overview
Founded in 2014 to advance technology developed at Tufts University and the University of Pittsburgh, Sofregen is a pioneer in the use of silk, nature's healing fiber, in a variety of forms to help physicians address soft tissue defects, giving patients a fresh start, restoring confidence, and improving quality of life.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jonathan Hartmann
Chief Scientific Officer
Anh Hoang
Browse more venture capital transactions:
Prev: 12/17/2019: Gecko Robotics venture capital transaction
Next: 12/18/2019: Anyscale venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on all VC transactions involving tech companies. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs